The Discounted Cash Flow (DCF) valuation of Cue Biopharma Inc (CUE) is (6.20) USD. With the latest stock price at 0.90 USD, the upside of Cue Biopharma Inc based on DCF is -788.7%.
Based on the latest price of 0.90 USD and our DCF valuation, Cue Biopharma Inc (CUE) is a sell. selling CUE stocks now will result in a potential gain of 788.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.4% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (15.90) - (3.89) | (6.20) |
| Upside | -1866.7% - -531.9% | -788.7% |